M&A Deal Summary |
|
|---|---|
| Date | 2018-09-21 |
| Target | Allergan - Medical Dermatology |
| Sector | Life Science |
| Buyer(s) | Almirall de Mexico S.A. de C.V. |
| Sellers(s) | Allergan |
| Deal Type | Divestiture |
| Deal Value | 650M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Almirall de Mexico, S.A. de C.V. is an international pharmaceutical company develops, produces and markets proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 2 of 2 |
| Country (Ireland) | 1 of 1 |
| Year (2018) | 1 of 1 |
| Size (of disclosed) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-17 |
Aqua Pharmaceuticals
West Chester, Pennsylvania, United States Aqua Pharmaceuticals LLC is a specialty dermatology pharmaceutical company focused on acquiring, developing and marketing under promoted, branded, pharmaceutical products. Utilizing its direct salesforce, Aqua promotes seven products throughout the United States including Monodox® (doxycycline monohydrate) capsules, an antibiotic used to treat acne; Cordran® lotion and cream, a topical corticosteroid used for the relief of inflammatory dermatoses; and Fluoroplex® (fluorouracil) cream, indicated for the treatment of actinic keratoses. |
Buy | $328M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-04 |
ThermiGen
Irving, Texas, United States ThermiGen LLC is a global manufacturer of temperature controlled radiofrequency technology. The company's flagship product is ThermiRF, a platform technology that uses temperature as an endpoint for various minimally and non-invasive applications (ThermiTight, ThermiRase, ThermiSmooth Face, ThermiVa, etc.). Thermi also offers the Thermi250 device as the newest innovative RF for the body. Founded in 2012, Thermi is a US based company with its headquarters in Irving, Texas, and R&D in Boston, MA. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1956 |
| Sector | Life Science |
| Employees | 31,200 |
| Revenue | 15.8B USD (2018) |
Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 9 |
| Sector (Life Science) | 6 of 7 |
| Type (Divestiture) | 8 of 9 |
| Country (Ireland) | 1 of 1 |
| Year (2018) | 1 of 1 |
| Size (of disclosed) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-14 |
Bonti
Newport Beach, California, United States Bonti, Inc. is an innovative clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin products for aesthetic and therapeutic applications. By turning the science of neurotoxins into beneficial patient and healthcare provider solutions, Bonti seeks to improve lives by successfully addressing key unmet needs in markets with significant addressable opportunities. |
Buy | $195M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-26 |
Envy Medical
Long Beach, California, United States Envy Medical, Inc. develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. Envy Medical, Inc. was founded in 2002 and is based in Long Beach, California. |
Buy | - |
